Noble Financial Estimates Cosmos Health Q3 Earnings

Cosmos Health Inc. (NASDAQ:COSM) – Investment analysts at Noble Financial issued their Q3 2026 earnings estimates for Cosmos Health in a research note issued on Monday, October 26th. Noble Financial analyst M. Kupinski anticipates that the company will post earnings per share of ($0.02) for the quarter. Noble Financial has an “Outperform” rating on the stock. The consensus estimate for Cosmos Health’s current full-year earnings is ($0.22) per share. Noble Financial also issued estimates for Cosmos Health’s Q4 2026 earnings at $0.04 EPS, FY2026 earnings at ($0.08) EPS, Q1 2027 earnings at $0.02 EPS, Q2 2027 earnings at $0.02 EPS, Q3 2027 earnings at $0.02 EPS, Q4 2027 earnings at $0.02 EPS, FY2027 earnings at $0.07 EPS, FY2028 earnings at $0.14 EPS and FY2029 earnings at $0.20 EPS.

Cosmos Health (NASDAQ:COSM) last announced its quarterly earnings data on Tuesday, August 18th. The company reported ($0.10) earnings per share for the quarter, meeting the consensus estimate of ($0.10). The company had revenue of $19.32 million during the quarter, compared to the consensus estimate of $18.99 million.

Separately, Weiss Ratings raised Cosmos Health from a “sell (e+)” rating to a “sell (d-)” rating in a report on Thursday, July 30th. One research analyst has rated the stock with a Buy rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold”.

Cosmos Health Stock Up 1.5%

NASDAQ:COSM opened at $0.24 on Wednesday. Cosmos Health has a twelve month low of $0.16 and a twelve month high of $1.04. The stock’s 50 day moving average price is $0.30 and its two-hundred day moving average price is $0.32.

Insider Transactions at Cosmos Health

In other Cosmos Health news, CEO Grigorios Siokas purchased 349,825 shares of the stock in a transaction on Thursday, July 30th. The shares were purchased at an average price of $0.20 per share, with a total value of $69,965.00. Following the completion of the transaction, the chief executive officer directly owned 14,597,917 shares in the company, valued at $2,919,583.40. This represents a 2.46% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 26.15% of the company’s stock.

Institutional Inflows and Outflows

A hedge fund recently bought a new position in Cosmos Health stock. BlackRock Inc. purchased a new stake in Cosmos Health Inc. (NASDAQ:COSM) during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 267,797 shares of the company’s stock, valued at approximately $49,000. BlackRock Inc. owned 0.45% of Cosmos Health at the end of the most recent quarter. Institutional investors own 12.61% of the company’s stock.

More Cosmos Health News

Here are the key news stories impacting Cosmos Health this week:

• Positive Sentiment: Noble Capital reportedly set a $1.40 price target for Cosmos Health, implying substantial upside from recent trading levels, and maintained a favorable view of the shares. Noble Capital sets USD 1.40 target for Cosmos Health stock
• Positive Sentiment: The company expanded sales activity in Oceania, a development that could broaden distribution and support future revenue growth. Shares increased 3.16% on October 23 following the announcement. Cosmos Health expands Oceania sales
• Neutral Sentiment: Reported short interest was zero shares as of October 26, with a 0.0-day short-interest ratio. This suggests limited short-squeeze potential, while the unusual figure may reflect incomplete or inconsistent reporting.
• Negative Sentiment: Despite the long-term earnings improvement projected by Noble Financial, COSM remains below its 50-day and 200-day moving averages and is still expected to post a loss for fiscal 2026, highlighting ongoing profitability and execution risks.

About Cosmos Health

Cosmos Health Inc is a healthcare group that develops, manufactures and distributes pharmaceutical, nutraceutical and healthcare products. Its portfolio includes branded dietary supplements, vitamins and wellness products, as well as pharmaceutical products and medical devices distributed through retail, wholesale and online channels.

The company markets its nutraceutical products under the Sky Premium Life brand, which offers supplements and other health and wellness products. Cosmos Health also has manufacturing and product-development activities through Cana Laboratories, a Greece-based pharmaceutical manufacturer that produces pharmaceutical and healthcare products for its own portfolio and third parties.

Founded in 2009 and formerly known as Cosmos Holdings, the company adopted the Cosmos Health name in 2022.